Skip to main content

Peer Review reports

From: Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease

Original Submission
12 Dec 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
28 Dec 2022 Reviewed Reviewer Report
4 Jan 2023 Reviewed Reviewer Report
21 Jan 2023 Author responded Author comments - Ji Li
Resubmission - Version 3
21 Jan 2023 Submitted Manuscript version 3
24 Jan 2023 Reviewed Reviewer Report
31 Jan 2023 Reviewed Reviewer Report
2 Feb 2023 Author responded Author comments - Ji Li
Resubmission - Version 4
2 Feb 2023 Submitted Manuscript version 4
12 Feb 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
13 Feb 2023 Editorially accepted
8 Mar 2023 Article published 10.1186/s12876-023-02676-9

You can find further information about peer review here.

Back to article page